Targeted Orphaned Domain May Lead to Drug Therapies for Nervous System Diseases and Inflammatory Processes
Research key to possible drug therapies for nervous system diseases and inflammatory processes
"We are especially interested in the superfamily of pentameric ligand-gated ion channels (pLGICs) that includes the nAChR, GABA, 5-HT3, and glycine families," Jansen said. "The pLGICs function mainly as neurotransmitter receptors, transforming the chemical signal contained in the neurotransmitter into an electrical signal."
The current therapies make it impossible to precisely hit one target because there are more than 40 different subunits in humans. All the drugs currently in clinical use, target the extracellular or transmembrane domains, which are structurally very similar across different subunits.
Read the full story here.
Related Stories
38th Student Research Week Successful at Showcasing Secrets of Immune Defense
Student researchers at TTUHSC had the opportunity to showcase their presentation skills at the 38th Annual Student Research Week Feb. 25 – 27.
Celebrating Veterans: TTUHSC’s General Martin Clay’s Legacy of Service and Leadership
From his initial enlistment in the Army National Guard 36 years ago to his leadership in military and civilian health care management roles, Major General Martin Clay’s career has been shaped by adaptability, mission focus and service to others.
Texas Tech University Health Sciences Center School of Nursing Named Best Accelerated Bachelor of Science in Nursing Program in Texas
The TTUHSC School of Nursing Accelerated Bachelor of Science in Nursing (BSN) program has been ranked the No. 1 accelerated nursing program in Texas by RegisteredNursing.org.
Recent Stories
TTUHSC Experts Receive Junior Investigator Research Grants through Texas Alzheimer’s Research and Care Consortium
Texas Tech University Health Sciences Center (TTUHSC) researchers Aric Logsdon, Ph.D., and Jonathan Singer, Ph.D., received Junior Investigator Research Grants from the Texas Alzheimer’s Research and Care Consortium (TARCC).
CPRIT Awards TTUHSC Researcher $1.4 Million Cancer Grant in Efforts to Expand Rural Clinical Trials
The Cancer Prevention and Research Institute of Texas (CPRIT) awarded a $1.4 million grant to Erin Barr, M.D., a clinician of pediatric hematology/oncology and researcher in the School of Medicine at Texas TTUHSC. Barr’s research, “Enhancing access to pediatric oncology clinical trials in West Texas,” received funding under the Recruitment or Retention of Clinical Trialists Award.
Texas Tech University Health Sciences Center’s Klein Selected to Leadership Role by the Texas Pharmacy Association
The Texas Pharmacy Association announced (May 19) the appointment of Mary Klein, Pharm.D., as assistant vice president of Strategic Initiatives and Practice Innovation.